Home > Signaling Pathways>Transmembrane>Potassium Channel>Vonoprazan Fumarate (TAK-438)
Vonoprazan Fumarate (TAK-438)

This product is for research use only, not for human use. We do not sell to patients.

Vonoprazan Fumarate (TAK-438)
For small sizes, please check our retail website as below: www.invivochem.com
Size Price Stock
1g$150Check With Us
2g$245Check With Us
5g$390Check With Us

Cat #: V1677 CAS #: 1260141-27-2 Purity ≥ 98%

Description: Vonoprazan Fumarate (formerly TAK-438, TAK 438, trade name Takecab), the fumarate salt of Vonoprazan, is a novel, orally bioactive and potent P-CAB (potassium-competitive acid blocker) that has been approved in Janpan in 2015 for the treatment of gastroduodenal ulcer and reflux esophagitis.

References: Arikawa Y, et al. Discovery of a novel pyrrole derivative 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine fumarate (TAK-438) as a potassium-competitive acid blocker (P-CAB). J Med Chem, 2012, 55(9), 4446-4456.

Top Publications Citing Invivochem Products
Publications Citing InvivoChem Products

Product Promise

Promise
Molecular Weight (MW)461.46
Molecular FormulaC17H16FN3O2S.C4H4O4
CAS No.1260141-27-2
Storage-20℃ for 3 years in powder formr
-80℃ for 2 years in solvent
Solubility In VitroDMSO: 62 mg/mL (134.4 mM)r
Water:<1 mg/mLr
Ethanol:<1 mg/mL
Solubility In Vivo0.5% methylcellulose: 17 mg/mL
SynonymsTAK438, Vonoprazan Fumarate, TAK-438, TAK 438, Takecab
ProtocolIn VitroVonoprazan does not inhibit Na+,K+-ATPase activity, even at concentrations 500 times higher than their IC50 values against gastric H+,K+-ATPase activity
In VivoVonoprazan (1-4 mg/kg; p.o.) completely inhibits basal and 2-deoxy-D-glucose (2DG, 200 mg/kg s.c.)-stimulated gastric acid secretion at the 4 mg/kg dose in rats
Animal modelMale 7- or 8-week-old Sprague-Dawley rat
Dosages0.5, 1, 2, and 4 mg/kg
AdministrationOral administration
These protocols are for reference only. InvivoChem does not independently validate these methods.
Preparing Stock Solutions
Solvent volume to be added Mass (the weight of a compound)
Mother liquor concentration 1mg5mg10mg20mg
1mM2.1670 mL10.8352 mL21.6704 mL43.3407 mL
5mM0.4334 mL2.1670 mL4.3341 mL8.6681 mL
10mM0.2167 mL1.0835 mL2.1670 mL4.3341 mL
20mM0.1084 mL0.5418 mL1.0835 mL2.1670 mL
Quality Control Documentation
The molarity calculator equation
Mass(g) = Concentration(mol/L) × Volume(L) × Molecular Weight(g/mol)
Mass
=
Concentration
×
Volume
×
Molecular Weight*
The dilution calculator equation
Concentration(start) × Volume(start) = Concentration(final) × Volume(final)

This equation is commonly abbreviated as: C1 V1 = C2 V2

Concentration(start)
C1
×
Volume(start)
V1
=
Concentration(final)
C2
×
Volume(final)
V2
Step One: Enter information below
Dosage mg/kg Average weight of animals g Dosing volume per animal µL Number of animals
Step Two: Enter the in vivo formulation
%DMSO + % + %Tween 80 + %ddH2O

Calculation Results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in µL DMSO(Master liquid concentration mg/mL) ,Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation: Take µL DMSO master liquid, next add µL PEG300, mix and clarify, next add µL Tween 80,mix and clarify, next add µL ddH2O,mix and clarify.
Note:
  • (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
  • (2) Be sure to add the solvent(s) in order.